Replacing The TQT With Exposure-QT Response Study
Source: Medpace
Proarrhythmic Potential For Nonantiarrhythmic Drugs, which introduced the concept of the Through QT (TQT), study was recently revised to include the opportunity to demonstrate the cardiac safety of a new drug by utilizing Exposure-QT response study data in dose escalation and other studies. This now gives sponsors a choice between TQT and Exposure-QT studies.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Medpace
This website uses cookies to ensure you get the best experience on our website. Learn more